The association of peripheral perfusion with maro-circulation and prognosis in patients undergoing surgery for pheochromocytoma and paraganglioma

The association of peripheral perfusion with maro-circulation and prognosis in patients undergoing surgery for pheochromocytoma and paraganglioma: a prospective cohort study

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2400086417

Enrollment

Unknown

Registered

2024-07-01

Start date

2023-09-19

Completion date

Unknown

Last updated

2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pheochromocytoma and Paraganglioma

Interventions

Exposure group (Peripheral perfusion index < 1.6):NA

Non-exposure group (Peripheral perfusion index=1.6):NA

Eligibility

Sex/Gender

All

Age

18 Years to 100 Years

Inclusion criteria

Inclusion criteria: ? = 18 years old ? Clinical diagnosis of pheochromocytoma or paraganglioma ? Prepared for surgical resection

Exclusion criteria

Exclusion criteria: ? Peripheral perfusion index not obtained ? Combined with peripheral vascular diseases ? Written informed consent not obtained

Design outcomes

Primary

Measure	Time frame
Postoperative complications within 30 days;	—

Secondary

Measure	Time frame
ICU/In hospital mortality;ICU / Postoperative hospital stay;Postoperative mechanical ventilation;Postoperative hypotension ;Macro circulation;	—

Countries

China

Contacts

Public ContactLi Nan

Peking University First Hospital

iculinan@163.com+86 138 1045 9905

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026